Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles l'Allemain

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|September 6, 2002
[Report on 93rd AACR]Gilles L'Allemain
Bulletin Du Cancer|March 30, 2004
[Absence of the Fos oncogene induces rhabdomyosarcoma in the p53(-/-) mouse]Gilles L'Allemain
Bulletin Du Cancer|February 7, 2004
[HER-ErbB family of receptors and their ligands: mechanisms of activation, signals and deregulation in cancer]Gilles L'Allemain
Bulletin Du Cancer|January 13, 2015
[NSAID use reduces the risk of breast cancer recurrence in overweight and obese women]Gilles L'Allemain
Bulletin Du Cancer|February 16, 2002
[Update on . . . the proteasome inhibitor PS341]Gilles L'Allemain
Bulletin Du Cancer|January 7, 2004
[An original mechanism of action for TIMP2, a tissue-inhibitor of matrix metalloproteinases]Gilles L'Allemain
Bulletin Du Cancer|June 7, 2011
[Chromotripsy]Gilles L'Allemain
Bulletin Du Cancer|July 30, 2004
[Cancer prevention: congress report]Gilles L'Allemain
Bulletin Du Cancer|November 12, 2003
[Ras signals up there where no one expects it]Gilles L'Allemain
Bulletin Du Cancer|January 7, 2004
Gilles L'Allemain
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|September 6, 2002
[Report on 93rd AACR]Gilles L'Allemain
Bulletin Du Cancer|March 30, 2004
[Absence of the Fos oncogene induces rhabdomyosarcoma in the p53(-/-) mouse]Gilles L'Allemain
Bulletin Du Cancer|February 7, 2004
[HER-ErbB family of receptors and their ligands: mechanisms of activation, signals and deregulation in cancer]Gilles L'Allemain
Bulletin Du Cancer|January 13, 2015
[NSAID use reduces the risk of breast cancer recurrence in overweight and obese women]Gilles L'Allemain
Bulletin Du Cancer|February 16, 2002
[Update on . . . the proteasome inhibitor PS341]Gilles L'Allemain
Bulletin Du Cancer|January 7, 2004
[An original mechanism of action for TIMP2, a tissue-inhibitor of matrix metalloproteinases]Gilles L'Allemain
Bulletin Du Cancer|June 7, 2011
[Chromotripsy]Gilles L'Allemain
Bulletin Du Cancer|July 30, 2004
[Cancer prevention: congress report]Gilles L'Allemain
Bulletin Du Cancer|November 12, 2003
[Ras signals up there where no one expects it]Gilles L'Allemain
Bulletin Du Cancer|January 7, 2004
Gilles L'Allemain
Pageof 5